TC
RVLP

Titleist Capital’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Titleist Capital’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$104K Sell
92,503
-5,648
-6% -$9K 0.02% 232
2022
Q3 		$206K Sell
98,151
-20,152
-17% -$39.2K 0.05% 210
2022
Q2 		$161K Buy
118,303
+15,033
+15% +$21.8K 0.04% 223
2022
Q1 		$175K Buy
103,270
+23,086
+29% +$33K 0.03% 248
2021
Q4 		$87K Buy
+80,184
New +$130K 0.02% 239

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Titleist Capital's RVLP Position: Q4 2022 in Review

Titleist Capital reduced its RVL Pharmaceuticals plc Ordinary Shares (RVLP) stake by 5.8% in Q4 2022, selling an estimated $9K and leaving 92,503 shares worth $104K. The position accounts for 0.02% of the portfolio, ranked #232.

Titleist Capital first reported a position in RVLP in Q4 2021 and has held it in 5 quarters since. The position peaked at $206K in Q3 2022. 36 funds tracked by Wall St. Rank hold RVLP as of Q4 2022.

  • Titleist Capital held 92,503 shares of RVL Pharmaceuticals plc Ordinary Shares worth $104K as of Q4 2022.
  • Titleist Capital sold 5,648 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2022, an estimated $9K.
  • RVL Pharmaceuticals plc Ordinary Shares made up 0.02% of Titleist Capital's portfolio in Q4 2022, its #232 holding.
  • Titleist Capital first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2021 and has held it in 5 quarters since.
  • Titleist Capital's RVL Pharmaceuticals plc Ordinary Shares position peaked at $206K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2022.

Based on Titleist Capital's 13F filing for Q4 2022, filed 12 Jan 2023.